Publications & Presentations

The following is a list of publications and presentations authored and presented by our clinical staff:

publications

Leisegang R, Maartens G, Hislop M, Regensberg L, Cleary S. Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings. BMC Health Serv Res. 2010 Jul 2;10 Suppl 1:S3.

Nachega JB, Leisegang R, Bishai D, Nguyen H, Hislop M, Cleary S, Regensberg L, Maartens G. Association of antiretroviral therapy adherence and health care costs. Annals of Internal Medicine. 2010 Jan 5;152(1):18-25.

Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, Cotton M, Maartens G. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. Journal of acquired immune deficiency syndromes. 2009 May 1; 51, 65–71.

Leisegang R, Cleary S, Hislop M, Davidse A, Regensberg L, Little F, Maartens G. Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis. PLoS Med. 2009 Dec;6(12):e1000189. Epub 2009 Dec 1.

Nachega JB, Hislop M, Dowdy DW, Gallant JE, Chaisson RE, Regensberg L, Maartens G. Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults. AIDS. 2008 Oct 18;22(16):2117-25.

Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, Regensberg L, Frank I, Maartens G, Nachega JB. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Medicine. 2008 May 20;5(5):e109.

Stevens M, Sinanovic E, Regensberg L, Hislop M. HIV and AIDS, STI and TB in the Private Sector. 14, 201-211. In: Harrison S, Bhana R, Ntuli A, editors. South African Health Review 2007. Durban: Health Systems Trust; 2007. URL: http://www.hst.org.za/publications/711

Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Adherence to Non-Nucleoside Reverse Transcriptase-based HIV Therapies and Virologic Outcomes. Annals of Internal Medicine. 2007:146(8):564-73.

Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, Chaisson RE, Maartens G. Adherence to Highly Active Antiretroviral Therapy As Assessed by Pharmacy Claims Predicts Survival in HIV-infected South African Adults. Journal of Acquired Immune Deficiency Syndromes, 2006, Volume 43, Number 1, 78-84.

Hislop M, Regensberg L. Enrolment experience and the measurement of survival in a private sector HIV/AIDS disease management programme. South African Journal of HIV Medicine. May 2004, 15 – 17.

Regensberg L, Hislop M. Maximising the benefits of antiretroviral therapy: what have we learnt in the private sector? AIDS Analysis Africa. February 2004.

Cowlin R, Regensberg L, Hislop M: Counting the Cost of Care: do HIV/AIDS Disease Management Programmes Deliver? AIDS Management Report, 2003, 1(3), 20 – 23.

Regensberg L, Hislop M. Aid for AIDS: A report back on more than four years of HIV/AIDS disease management in Southern Africa. South African Journal of HIV Medicine. Feb 2003, 7 - 10.

Regensberg L, Pead C, Mahumapelo J, Cotton M. Prevention of vertical transmission of human immunodeficiency type 1 virus in a managed care setting. South African Medical Journal 2000, 90(11), 1092-1093.

Regensberg L. Post-exposure and vertical transmission prophylaxis. Modern Medicine, November/December 1999; 24: 36-40.

Regensberg L, Maartens G. Antiretroviral therapy in adults. Modern Medicine, October 1999; 24: 30-38.

Regensberg L, Maartens G. Assessing newly diagnosed HIV patients. Modern Medicine, August 1999; 24: 58-64.

Regensberg L. HIV and AIDS - an overview. Modern Medicine, June 1999; 24: 51-54.

Regensberg L, Cowlin J, et al. Affordable management of HIV infection in the private sector. South African Medical Journal 1998; 88:945-948.


academic conferences - oral presentations

J.B. Nachega, R Leisegang, M.S. Hislop, S. Cleary, D Bishai, H. Nguyen, L Regensberg, G Maartens. Excellent Adherence to Antiretroviral Therapy Predicts Lower Direct Health Care Costs for HIV-infected Adults. South African AIDS Conference, Durban April 2009.

Matoti L., Hislop M.S., Regensberg L.D., Cotton M.HIV-1 infected adolescents: treatment experience in a managed care setting in South Africa. South African AIDS Conference, Durban June 2007.

Nachega J, Hislop M, Dowdy D, L.D.Regensberg, R.E.Chaisson, G.Maartens. Efavirenz vs. Nevirapine-based Antiretroviral Therapy Regimens: Adherence and Virologic Outcomes. 14th Conference on Retroviruses and Opportunistic Infections (CROI), Los Angeles, Calif., USA Feb 25-28, 2007.

Nachega J, Hislop M, Dowdy D, L.D.Regensberg, R.E.Chaisson, G.Maartens. HAART Adherence to NNRTIs-based Regimen and Virologic Outcomes in HIV-infected South Adults. 13th Conference on Retroviruses and Opportunistic Infections (CROI), Denver, Colo., USA Feb 5-9, 2006.

J.B.Nachega, M.S.Hislop, D.Dowdy, M.Lo, O.Saad, L.D.Regensberg, R.E.Chaisson, G.Maartens. HAART Adherence as assessed by Pharmacy Claims Predicts Survival in HIV-infected South African Adults. 12th Conference on Retroviruses and Opportunistic Infections (CROI), Boston, Mass., USA Feb 22-25, 2005, Ab#Or25.

FJ Arens, MS Hislop, E Sinanovic, L Regensberg, G Maartens. Treatment costs for HIV/AIDS in a managed care setting in South Africa. South African Pharmacology Conference, Bloemfontein October 2004.

N Hlatshwayo, M S Hislop, M Cotton, G Maartens, L D Regensberg. Mother to child HIV transmission prevention (MTCTP) in a managed care setting in South Africa - no role for short-term antiretroviral therapy (ART)? . 15th World AIDS Conference, Bangkok 2004.

K van Huyssteen. An Internet Based Solution for Providing Remote Access to an HIV/AIDS Disease Management Programme in Africa. Health Informatics in Africa Conference (HELINA) October 2003.

K van Huyssteen. Use of Electronic Adjudication Methodology as Part of a Disease Management Programme. Health Informatics in Africa Conference (HELINA) October 2003.

Hislop M, Maartens G, Regensberg L. The influence of CD4 count at antiretroviral therapy (ART) commencement on survival in HIV/AIDS patients in a managed healthcare setting. South African AIDS Conference Durban, August 2003.

Hislop M, Maartens G, Regensberg L. Adherence to antiretroviral therapy (ART) in a managed healthcare setting: demographic influences and effect on survival. South African AIDS Conference Durban, August 2003.

Hislop M, Regensberg L. HIV/AIDS in seniors: Four years experience in providing access to antiretroviral therapy (ART) to older adults in a managed healthcare setting. Geriatrix Africa Conference, Cape Town, March 2003.


academic conferences - poster presentations

L. Dunn, M. Coetsee, L. Regensbert, M. Hislop, G. Maartens, G. Meintjies. Virological response to antiretroviral salvage therapy in the Southern African private sector. South African HIV Clinicians Society Conference, Cape Town, November 2012.

R. Leisegang, M. Hislop, L. Regensberg, J. Nachega, S. Cleary, G. Maartens. Delivering antiretroviral therapy by courier pharmacy is associated with improved outcomes. Abstract no. MOPE190. 6th International AIDS Society Conference, Rome 2011.

R Leisegang, J Nachega, M Hislop, and G Maartens. The impact of pregnancy on adherence to and defaulting from antiretroviral therapy. 18th Conference on Retroviruses and Opportunistic Infections (CROI), Boston, Massachusetts, USA Feb 27-Mar 2, 2011.

Makgoba S, Laverack S, De Koker R, Naude J, Hislop MS, Manyike PT, Tucker TJ. Compulsory health information sessions coupled with a comprehensive wellness program and proactive follow-up demonstrates high voluntary HIV test and disease management uptake in a large South African mining company. 18th World AIDS Conference, Vienna 2010.

R. Leisegang, S. Cleary, M. Hislop, A. Davidse, L. Regensberg, G. Maartens. Early and late determinants of direct costs in a Southern African antiretroviral programme. WEPEB285. 5th International AIDS Society Conference, Cape Town, 2009.

Lucy Brennan, Michael Hislop, Leon Regensberg and Gary Maartens. Aid for AIDS – 10 years of experience in providing a private sector HIV disease management program in Sub-Saharan Africa. 17th World AIDS Conference, Mexico City 2008.

Nachega J, Hislop M, Dowdy D, L.D.Regensberg, R.E.Chaisson, M Cotton, G.Maartens. Virologic Outcomes and Antiretroviral Therapy Adherence in Adolescents Compared with Adults in Southern Africa. 15th Conference on Retroviruses and Opportunistic Infections (CROI), Boston, MA , USA, Feb 3-6, 2008.

Colleen Whitelaw, Michael Hislop, Leon Regensberg, and Graeme Meintjes. Reverse Transcriptase Drug Resistance Mutations Amongst a Treatment Experienced Cohort in a Subtype C Epidemic. South African AIDS Conference, Durban June 2007.

K R van Huyssteen, M S Hislop, C A Whitelaw, A M Strydom, L D Regensberg. Expansion of an electronic adjudication system to monitor disease progression and effectiveness of therapy as part of a disease management programme (DMP). 15th World AIDS Conference, Bangkok 2004.

Hislop M, Regensberg L. The influence of age and gender on HIV/AIDS outcomes in adults in a managed healthcare setting. South African AIDS Conference, Durban 2003.

Regensberg L, Andrews S, Pead C, Maartens G, Nortier S. Unrecognised interactions between antiretrovirals and concomitant chronically administered medication in a managed healthcare programme in Southern Africa. 14th World AIDS Conference, Barcelona 2002.

Cotton M, Hislop M, Regensberg L, Pead C. Antiretroviral therapy in South African children with access to managed care. 14th World AIDS Conference, Barcelona 2002.

Regensberg L, Pead C, Hislop M, Maartens G. Providing Antiretroviral therapy in a Resource Limited Setting: Two year experience of an HIV Disease Management Programme in South Africa. 13th World AIDS Conference, Durban 2000.


business conferences

Cowlin R. Facts and Practical Solutions for Managing HIV/AIDS. Institute of People Management, Johannesburg, August 2003.

Regensberg L, Hislop M. Update on the Aid for AIDS programme. Actuarial Society of South Africa, Healthcare CPD Event, Cape Town, June 2003.

Hislop M. Latest HIV/AIDS projections, impact of interventions and strategies for the future. Institute for International Research, Health Care Structure Johannesburg, February 2003.

Regensberg L, Hislop M. HIV/AIDS in the South African private health care sector. Actuarial Society of South Africa, Healthcare CPD Event, Johannesburg, June 2002.


medical conferences

Hislop M. Costs of HIV treatment in the private sector. South African HIV Clinicians Society Conference, Cape Town, November 2012.

Regensberg L. Managing HIV/AIDS in the Private Sector. Medical Advisors Group Conference, Johannesburg, August 2003.

Regensberg L, Hislop M. HIV/AIDS in the South African private health care sector: Four Years On... South African HIV Clinicians Society. Johannesburg, May 2002.


briefing sessions

Regensberg L, Hislop M. Update on HIV/AIDS disease management in South Africa. Journ-AIDS Roundtable, Cape Town, May 2003.

Regensberg L, Hislop M, Ngogodo L, Laverack S. HIV/AIDS in the South African private health care sector. The Aid for AIDS experience. Parliament, February 2002.

Regensberg L, Hislop M, Laverack S. Managing the impact of HIV/AIDS in corporate South Africa. ABSA Corporate & Merchant Bank. October 2001.

Walters L. Managing the Impact of HIV/AIDS in Medical Schemes. HSBC Holdings plc, Cape Town, August 2001.

patient care line
0860 100 646

doctor/pharmacist
0800 227 700

cape town office
+27 (0)21 466 1700

fax
0800 600 773
+27 (0)21 466 1771

Email Address afa@afadm.co.za